PH-797804
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for PH-797804, covering 2011-02-15 to 2018-11-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate [Phase 2]